HomeBSLN • SWX
add
Basilea Pharmaceutica AG Allschwil
Previous close
CHF 52.30
Day range
CHF 51.90 - CHF 52.70
Year range
CHF 37.50 - CHF 59.70
Market cap
701.98M CHF
Avg Volume
39.24K
P/E ratio
17.92
Dividend yield
-
Primary exchange
SWX
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 64.21M | -2.90% |
Operating expense | 8.93M | 11.90% |
Net income | 12.22M | -57.02% |
Net profit margin | 19.03 | -55.73% |
Earnings per share | — | — |
EBITDA | 14.91M | -44.88% |
Effective tax rate | 7.89% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 159.80M | 32.38% |
Total assets | 282.00M | 9.40% |
Total liabilities | 154.06M | -12.85% |
Total equity | 127.94M | — |
Shares outstanding | 12.29M | — |
Price to book | 5.02 | — |
Return on assets | 12.35% | — |
Return on capital | 16.04% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 12.22M | -57.02% |
Cash from operations | 19.52M | -30.84% |
Cash from investing | -1.22M | -92.45% |
Cash from financing | -3.48M | -31,513.64% |
Net change in cash | 14.81M | -46.24% |
Free cash flow | 9.72M | -45.52% |
About
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
CEO
Founded
2000
Website
Employees
189
